Abstract:Background Pancreatic adenocarcinoma (PAAD) is a highly aggressive and malignant cancer type characterized by few early symptoms and high mortality. Mitochondrial dynamics-related genes (MDRGs) can affect various processes during cancer development directly or indirectly. The area of MDRGs as biomarkers remains unexplored in PAAD. Methods The sequencing data and clinical information were from TCGA and GEO databases. The MDRGs were collected from MitoCarta, GO, and KEGG databases. The differentially expressed genes and overall survival-associated genes were selected with the R package 'limma' and univariate Cox regression. The prognostic signature was developed using lasso regression and multiple machine learning algorithms from the Python 'scikit-survival' library. The R package 'CIBERSORT' was used to evaluate the tumor microenvironment. The R package 'oncoPredict' was used to predict the IC50 score. The R package 'maftools' was used to visualize the somatic mutation. Results We obtained 37 genes through the intersection of differentially expressed genes (IDDF2024-ABS-0067 Figure 1. Identification of the 37 MDRGs (A)), overall survival-associated genes, and MDRGs (IDDF2024-ABS-0067 Figure 1. Identification of the 37 MDRGs (B)). GO and KEGG analysis of the 37 genes were performed (IDDF2024-ABS-0067 Figure 1. Identification of the 37 MDRGs (C-D)). A 12-gene prognostic signature was developed based on the 37 genes by multiple machine-learning algorithms (IDDF2024-ABS-0067 Figure 2. Construction of the machine learning signature (A)). The KM curves of the high-and low-risk groups demonstrated significant stratification in both the TCGA cohort and GSE62452 cohort (IDDF2024-ABS-0067 Figure 2. Construction of the machine learning signature (B-C)). Univariate and multiple Cox analysis validated the prognostic ability of the 12 genes and highlighted FAM73B as a potential biomarker (IDDF2024-ABS-0067 Figure 2. Construction of the machine learning signature (D-E)). The infiltration level of macrophages, monocytes, and CD8+ T cells showed significant differences between the high- and low-risk groups. The high-and low-risk groups exhibited distinct sensitivity to Gemcitabine and Paclitaxel (IDDF2024-ABS-0067 Figure 3. Immune infiltration, drug sensitivity, and somatic mutational features of high-and low-risk groups (A-D)). The somatic mutation between the groups was visualized in IDDF2024-ABS-0067 Figure 3. Immune infiltration, drug sensitivity, and somatic mutational features of high-and low-risk groups (E). Conclusions We developed an MDRG signature based on machine learning algorithms, providing new insights into the prognosis, drug sensitivity, tumor microenvironment, and somatic mutation for PAAD management.

Robust and consistent biomarker candidates identification by a machine learning approach applied to pancreatic ductal adenocarcinoma metastasis

Machine learning Algorithms and Biomarkers Identification for Pancreatic cancer Diagnosis Using Multi-Omics Data Integration

Data privacy-aware machine learning approach in pancreatic cancer diagnosis

Development of a diagnostic model for pancreatic ductal adenocarcinoma using machine learning and blood-based miRNAs

Establishment of Three Gene Prognostic Markers in Pancreatic Ductal Adenocarcinoma Using Machine Learning Approach

IDDF2024-ABS-0067 Construction and Validation of a Prognostic Signature of Pancreatic Adenocarcinoma Based on Multiple Machine Learning Algorithms Associated with Mitochondrial Dynamics-Related Genes

Machine Learning in Metastatic Cancer Research: Potentials, Possibilities, and Prospects

Early Diagnosis of Pancreatic Ductal Adenocarcinoma by Combining Relative Expression Orderings with Machine-Learning Method

Cancer Metastasis Prediction and Genomic Biomarker Identification through Machine Learning and eXplainable Artificial Intelligence in Breast Cancer Research

Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics

High-performance Collective Biomarker from Liquid Biopsy for Diagnosis of Pancreatic Cancer Based on Mass Spectrometry and Machine Learning

A powerful machine learning approach to identify interactions of differentially abundant gut microbial subsets in patients with metastatic and non-metastatic pancreatic cancer

A novel method for detection of pancreatic Ductal Adenocarcinoma using explainable machine learning

Identification of Key mRNAs as Prediction Models for Early Metastasis of Pancreatic Cancer Based on LASSO

Key genes and pathways in the molecular landscape of pancreatic ductal adenocarcinoma: A bioinformatics and machine learning study

Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma

Predictive machine learning models for survival outcomes in patients with pancreatic cancer.

Machine Learning Driven Biomarker Selection for Medical Diagnosis

Novel machine‐learning model for predicting lymph node metastasis in resectable pancreatic ductal adenocarcinoma

Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNAbased diagnostic model

Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma